BPA
BSX icon

Beacon Pointe Advisors’s Boston Scientific BSX Stock Holding History

Beacon Pointe Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$679K Sell
15,843
-5,939
-27% -$322K ﹤0.01% 1198
2026
Q1 		$1.37M Buy
21,782
+7,500
+53% +$600K 0.01% 877
2025
Q4 		$1.36M Buy
14,282
+1,187
+9% +$116K 0.01% 728
2025
Q3 		$1.28M Sell
13,095
-1,233
-9% -$128K 0.01% 678
2025
Q2 		$1.54M Buy
14,328
+1,174
+9% +$119K 0.02% 542
2025
Q1 		$1.33M Sell
13,154
-902
-6% -$90.8K 0.01% 566
2024
Q4 		$1.26M Sell
14,056
-6,853
-33% -$603K 0.01% 582
2024
Q3 		$1.75M Sell
20,909
-1,127
-5% -$88.8K 0.02% 494
2024
Q2 		$1.7M Sell
22,036
-542
-2% -$39.7K 0.02% 509
2024
Q1 		$1.55M Buy
22,578
+930
+4% +$59.8K 0.02% 557
2023
Q4 		$1.25M Sell
21,648
-703
-3% -$37.5K 0.02% 598
2023
Q3 		$1.18M Buy
22,351
+9,263
+71% +$486K 0.01% 582
2023
Q2 		$708K Sell
13,088
-2,005
-13% -$105K 0.01% 620
2023
Q1 		$755K Buy
15,093
+250
+2% +$11.8K 0.01% 624
2022
Q4 		$687K Buy
14,843
+1,785
+14% +$77.3K 0.01% 596
2022
Q3 		$500K Buy
13,058
+254
+2% +$10.2K 0.01% 638
2022
Q2 		$478K Sell
12,804
-7,548
-37% -$307K 0.01% 667
2022
Q1 		$901K Buy
20,352
+12,113
+147% +$525K 0.01% 651
2021
Q4 		$350K Buy
8,239
+358
+5% +$15K 0.01% 674
2021
Q3 		$342K Buy
7,881
+258
+3% +$11.4K 0.01% 657
2021
Q2 		$326K Buy
+7,623
New +$321K 0.01% 638

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $782B AUM 28.39% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Beacon Pointe Advisors's BSX Position: Q2 2026 in Review

Beacon Pointe Advisors reduced its Boston Scientific (BSX) stake by 27% in Q2 2026, selling an estimated $322K and leaving 15,843 shares worth $679K. The position accounts for ﹤0.01% of the portfolio, ranked #1198.

Beacon Pointe Advisors first reported a position in BSX in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.75M in Q3 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Beacon Pointe Advisors held 15,843 shares of Boston Scientific worth $679K as of Q2 2026.
  • Beacon Pointe Advisors sold 5,939 Boston Scientific shares in Q2 2026, an estimated $322K.
  • Boston Scientific made up ﹤0.01% of Beacon Pointe Advisors's portfolio in Q2 2026, its #1198 holding.
  • Beacon Pointe Advisors first reported a position in Boston Scientific in Q2 2021 and has held it in 21 quarters since.
  • Beacon Pointe Advisors's Boston Scientific position peaked at $1.75M in Q3 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Beacon Pointe Advisors's 13F filing for Q2 2026, filed 18 Aug 2026.